Oxidants induce alternative splicing of α-synuclein: Implications for Parkinson's disease SV Kalivendi, D Yedlapudi, CJ Hillard, B Kalyanaraman Free Radical Biology and Medicine 48 (3), 377-383, 2010 | 64 | 2010 |
Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model D Yedlapudi, GS Joshi, D Luo, SV Todi, AK Dutta Scientific reports 6 (1), 38510, 2016 | 57 | 2016 |
Novel multifunctional dopamine D2/D3 receptors agonists with potential neuroprotection and anti-alpha synuclein protein aggregation properties D Luo, H Sharma, D Yedlapudi, T Antonio, MEA Reith, AK Dutta Bioorganic & medicinal chemistry 24 (21), 5088-5102, 2016 | 26 | 2016 |
Design, synthesis, and pharmacological characterization of carbazole based dopamine agonists as potential symptomatic and neuroprotective therapeutic agents for Parkinson’s disease A Elmabruk, B Das, D Yedlapudi, L Xu, T Antonio, MEA Reith, AK Dutta ACS Chemical Neuroscience 10 (1), 396-411, 2018 | 24 | 2018 |
Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1, 2, 3, 4-tetrazolyl] podophyllotoxins as anticancer compounds I Hyder, D Yedlapudi, SV Kalivendi, J Khazir, T Ismail, N Nalla, S Miryala, ... Bioorganic & Medicinal Chemistry Letters 25 (14), 2860-2863, 2015 | 24 | 2015 |
The Chaperone-Like Activity of α-Synuclein Attenuates Aggregation of Its Alternatively Spliced Isoform, 112-Synuclein In Vitro: Plausible Cross-Talk between … KM Manda, D Yedlapudi, S Korukonda, S Bojja, SV Kalivendi PloS one 9 (6), e98657, 2014 | 21 | 2014 |
Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with … D Yedlapudi, L Xu, D Luo, GB Marsh, SV Todi, AK Dutta Scientific Reports 9 (1), 19648, 2019 | 14 | 2019 |
First total synthesis and structure confirmation of diacetylenic polyol (+)-oploxyne B P Srihari, AS Reddy, JS Yadav, D Yedlapudi, SV Kalivendi Tetrahedron Letters 54 (41), 5616-5618, 2013 | 13 | 2013 |
Identification of an alternatively spliced α-synuclein isoform that generates a 41-amino acid N-terminal truncated peptide, 41-syn: role in dopamine homeostasis RL Vinnakota, D Yedlapudi, KM Manda, K Bhamidipati, KT Bommakanti, ... ACS chemical neuroscience 9 (12), 2948-2958, 2018 | 12 | 2018 |
Toxicoproteomic Analysis of Poly (ADP-Ribose)-Associated Proteins Induced by Oxidative Stress in Human Proximal Tubule Cells A Islas-Robles, D Yedlapudi, SS Lau, TJ Monks Toxicological Sciences 171 (1), 117-131, 2019 | 1 | 2019 |
Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein B Dinda, B Das, S Biswas, H Sharma, C Armstrong, D Yedlapudi, ... Bioorganic & medicinal chemistry 78, 117131, 2023 | | 2023 |
Supplementary Materials Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila … D Yedlapudi, GS Joshi, D Luo, SV Todi, AK Dutta | | |